MSN Labs Peru SAC Pharmaceutical Import Profile — Peru (DGFT 2022–2026)

Name: MSN Labs Peru SAC Pharmaceutical Import Records from India — 4 Products, $847.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

MSN Labs Peru SAC — Pharmaceutical Importer Profile (2026) | 4 Products, $847.6K Trade | TransData Nexus

MSN Labs Peru SAC

Pharmaceutical Importer · Peru · Advanced Oncology Focus · $847.6K Total Trade · DGFT Verified

MSN Labs Peru SAC is a pharmaceutical importer based in Peru with a total trade value of $847.6K across 4 products in 1 therapeutic categories. Based on 19 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. MSN Labs Peru SAC sources from 1 verified Indian supplier, with Msn Laboratories Private Limited accounting for 100.0% of imports.

MSN Labs Peru SAC — Import Portfolio & Supplier Network

MSN Labs Peru SAC import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to MSN Labs Peru SAC?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Msn Laboratories Private Limited	$4.3M	275	100.0%

MSN Labs Peru SAC sources from 1 verified Indian supplier across 222 distinct formulations. The sourcing is highly concentrated — Msn Laboratories Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Birato 250MG (abirateroneacetat 1x120) msn	$350.0K	7
Birato 250MG (abiraterone acetat 1x120)msn	$150.0K	3
Dasaphil 50 (dasatinib50 MG ) 3x10s	$102.9K	3
Birato 250MG (abiraterone acetat 1x120)msn	$91.8K	2
Emcap 500 (capecitabine 500MG)	$90.5K	3
Nuclofar 20 clofarabine 1x1's msn	$65.2K	2
Macitent 10MG(macitentant 3x10's)msn	$63.8K	2
Xatiza 60-(cabazitaxel INJ 1x1's) -msn	$58.8K	2
Clotsafe 75MG(10x10minsa cenares)msn	$57.7K	3
Apritant iv 150MG 1x1s	$56.0K	2
Voriole 200(1x10's)-voriconazole 200MG-msn	$55.9K	5
Msn pharmaceuticals product name: olmeheart 40 omesartan 3x10's-	$51.1K	2
Msn pharmaceuticals product name: azadual 100 MG azacitidine 1x1's- msn	$50.0K	1
Sutyka 25mgsunitinib 2x14's msn	$50.0K	1
Pomalid 4 md pomalidomide 4MG	$50.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dasatinib	Advanced Oncology	$310.4K	7	1.9%	13
2	Pomalidomide	Advanced Oncology	$300.0K	6	6.8%	3
3	Sunitinib	Advanced Oncology	$200.0K	4	0.3%	15
4	Erlotinib	Advanced Oncology	$37.2K	2	1.4%	13

MSN Labs Peru SAC imports 4 pharmaceutical products across 1 categories into Peru totaling $847.6K.

MSN Labs Peru SAC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

MSN Labs Peru S.A.C. is a wholly owned subsidiary of MSN Laboratories Private Limited, a Hyderabad-based pharmaceutical company established in 2003. The subsidiary was incorporated on January 25, 2018, and operates as a Sociedad Anónima Cerrada (closed corporation) in Peru. Headquartered in San Isidro, Lima, Peru, MSN Labs Peru S.A.C. focuses on the importation and distribution of pharmaceutical products, particularly in the oncology therapeutic area. The company's mission aligns with its parent company's goal of providing affordable and accessible healthcare solutions globally.

MSN Labs Peru S.A.C. has registered over 30 products for commercialization, emphasizing its commitment to expanding its portfolio and meeting the healthcare needs of the Peruvian market. The company employs a business-to-business (B2B) and sales force model, collaborating with other businesses in Peru to deliver health solutions effectively.

2Distribution Network

While specific details about MSN Labs Peru S.A.C.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic positioning in San Isidro, Lima, suggests a centralized distribution approach. This location provides access to major transportation routes and proximity to key healthcare institutions, facilitating efficient distribution across Peru. The company's focus on oncology products indicates a targeted distribution strategy to meet the needs of cancer patients nationwide.

3Industry Role

MSN Labs Peru S.A.C. operates primarily as a pharmaceutical importer and distributor, focusing on the oncology sector. By importing finished pharmaceutical formulations from its parent company, MSN Laboratories Private Limited, the subsidiary plays a crucial role in supplying specialized medications to the Peruvian market. This positions the company as a key player in the pharmaceutical supply chain, ensuring the availability of essential cancer treatments.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — MSN Labs Peru SAC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

MSN Labs Peru S.A.C. imports all its pharmaceutical products from a single supplier, MSN Laboratories Private Limited, indicating a high supplier concentration. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent shipment data and the parent company's established reputation in the pharmaceutical industry suggest a stable and reliable relationship. The strategic choice to source exclusively from MSN Laboratories Private Limited may also allow for streamlined operations and quality assurance.

2Supply Chain Resilience

The resilience of MSN Labs Peru S.A.C.'s supply chain is closely tied to its sole supplier, MSN Laboratories Private Limited. The lack of backup suppliers and limited formulation diversity could expose the company to risks if the primary supplier faces operational challenges. Additionally, the company's reliance on a single shipping route and potential exposure to regulatory changes in India may impact supply chain stability. Ensuring compliance with international quality standards and maintaining robust logistics planning are essential to mitigate these risks.

3Strategic Implications

Importing Pharmaceuticals into Peru — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Peru

1Regulatory Authority & Framework

In Peru, the General Directorate of Medicines, Supplies, and Drugs (DIGEMID) is the national authority responsible for regulating pharmaceutical products. Key legislation governing pharmaceutical imports includes Bill No. 29459 of 2019 and Supreme Decree No. 016-2011-SA, which establish requirements for product registration and marketing authorization. Indian generics seeking to enter the Peruvian market must navigate these regulatory pathways to ensure compliance and successful market entry. (pharmaconsulting.pe)

2Import Licensing & GMP

Import licensing requirements in Peru mandate that pharmaceutical companies obtain prior authorization from DIGEMID before marketing restricted products. This includes obtaining product registrations for medical equipment, devices, and pharmaceuticals. Additionally, foreign manufacturers must possess a Good Manufacturing Practices (GMP) certificate recognized by Peru, such as EU GMP, WHO GMP, or PIC/S certifications, to ensure product quality and safety. (pharmaconsulting.pe)

3Quality & Labeling

MSN Labs Peru SAC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

MSN Labs Peru S.A.C.'s focus on oncology products aligns with the growing demand for cancer treatments in Peru. The importation of medications such as Dasatinib, Pomalidomide, and Sunitinib addresses critical therapeutic needs, positioning the company to serve a significant patient population. This strategic focus reflects a commitment to improving healthcare outcomes in the oncology sector.

2Sourcing Profile

MSN Labs Peru S.A.C. employs a sourcing strategy centered on importing generic drugs from India, particularly from its parent company, MSN Laboratories Private Limited. The preference for finished dosage forms, including tablets, capsules, syrups, and injections, indicates a focus on ready-to-use products that meet international quality standards. This approach ensures a consistent supply of affordable and effective medications to the Peruvian market.

3Market Positioning

By importing a specialized portfolio of oncology products, MSN Labs Peru S.A.C. serves the hospital and specialized healthcare segments in Peru. The company's focus on high-quality, affordable cancer treatments positions it as a key supplier in the oncology market, catering to the needs of healthcare providers and patients requiring advanced therapeutic options.

Seller's Guide — How to Become a Supplier to MSN Labs Peru SAC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Peruvian market by offering high-quality oncology products that meet regulatory standards. Gaps in MSN Labs Peru S.A.C.'s current sourcing, such as the lack of backup suppliers and limited formulation diversity, present avenues for collaboration and supply chain diversification. Establishing partnerships with MSN Labs Peru S.A.C. could enhance supply chain resilience and provide competitive advantages in the Peruvian market.

2Requirements & Qualifications

Indian exporters aiming to supply MSN Labs Peru S.A.C. and the Peruvian market must obtain GMP certifications recognized by Peru, such as EU GMP, WHO GMP, or PIC/S. Additionally, compliance with Peruvian import licensing requirements, including product registration with DIGEMID, is essential. Adhering to quality standards and regulatory approvals is crucial for successful market entry and sustained business operations.

3How to Approach

Frequently Asked Questions — MSN Labs Peru SAC

What products does MSN Labs Peru SAC import from India?

MSN Labs Peru SAC imports 4 pharmaceutical products across 1 categories. Top imports: Dasatinib ($310.4K), Pomalidomide ($300.0K), Sunitinib ($200.0K), Erlotinib ($37.2K).

Who supplies pharmaceuticals to MSN Labs Peru SAC from India?

MSN Labs Peru SAC sources from 1 verified Indian suppliers. The primary supplier is Msn Laboratories Private Limited (100.0% of imports, $4.3M).

What is MSN Labs Peru SAC's total pharmaceutical import value?

MSN Labs Peru SAC's total pharmaceutical import value from India is $847.6K, based on 19 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does MSN Labs Peru SAC focus on?

MSN Labs Peru SAC imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full MSN Labs Peru SAC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.